EW
Edwards Lifesciences CorpNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$49.01B
P/E Ratio
46.01
EPS
$1.85
Beta
0.87
52W High
$89.48
52W Low
$72.30
50-Day MA
$82.78
200-Day MA
$81.84
Dividend Yield
—
Profit Margin
17.40%
Forward P/E
28.57
PEG Ratio
2.06
About Edwards Lifesciences Corp
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Fundamentals
| Revenue (TTM) | $6.30B |
| Gross Profit (TTM) | $4.91B |
| EBITDA | $1.90B |
| Operating Margin | 31.20% |
| Return on Equity | 10.50% |
| Return on Assets | 8.27% |
| Revenue/Share (TTM) | $10.81 |
| Book Value | $17.90 |
| Price-to-Book | 4.78 |
| Price-to-Sales (TTM) | 7.77 |
| EV/Revenue | 7.36 |
| EV/EBITDA | 29.77 |
| Quarterly Earnings Growth (YoY) | 8.20% |
| Quarterly Revenue Growth (YoY) | 16.70% |
| Shares Outstanding | $575.80M |
| Float | $573.99M |
| % Insiders | 0.18% |
| % Institutions | 94.07% |
Historical Volatility
HV 10-Day
24.20%
HV 20-Day
22.57%
HV 30-Day
26.41%
HV 60-Day
27.32%
HV Rank
72.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($96.92 target)
4
Strong Buy17
Buy8
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026